Blau Farmacêutica Past Performance
How has Blau Farmacêutica performed over the past 5 years?
Past Performance Score
3/6Past Performance Score 3/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
24.6%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: BLAU3 has a high level of non-cash earnings.
Growing Profit Margin: BLAU3's current net profit margins (26.2%) are higher than last year (22.2%).
Past Earnings Growth Analysis
Earnings Trend: BLAU3's earnings have grown significantly by 24.6% per year over the past 5 years.
Accelerating Growth: BLAU3's earnings growth over the past year (17.7%) is below its 5-year average (24.6% per year).
Earnings vs Industry: BLAU3 earnings growth over the past year (17.7%) exceeded the Biotechs industry -7.6%.
Return on Equity
High ROE: BLAU3's Return on Equity (19.1%) is considered low.